These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
414 related items for PubMed ID: 6534892
1. d-Fenfluramine and salbutamol: two drugs causing anorexia through different neurochemical mechanisms. Garattini S, Samanin R. Int J Obes; 1984; 8 Suppl 1():151-7. PubMed ID: 6534892 [Abstract] [Full Text] [Related]
6. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Garattini S, Mennini T, Bendotti C, Invernizzi R, Samanin R. Appetite; 1986; 7 Suppl():15-38. PubMed ID: 2427023 [Abstract] [Full Text] [Related]
7. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Garattini S, Bizzi A, Caccia S, Mennini T. Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321 [Abstract] [Full Text] [Related]
8. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat. Samanin R, Mennini T, Bendotti C, Barone D, Caccia S, Garattini S. Neuropharmacology; 1989 May; 28(5):465-9. PubMed ID: 2566947 [Abstract] [Full Text] [Related]
9. From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake. Garattini S, Mennini T, Samanin R. Ann N Y Acad Sci; 1987 May; 499():156-66. PubMed ID: 2440376 [Abstract] [Full Text] [Related]
10. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine. Duhault J, Boulanger M, Voisin C, Malen C, Schmitt H. Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366 [Abstract] [Full Text] [Related]
12. Progress in assessing the role of serotonin in the control of food intake. Garattini S, Bizzi A, Caccia S, Mennini T, Samanin R. Clin Neuropharmacol; 1988 Nov; 11 Suppl 1():S8-32. PubMed ID: 3052823 [Abstract] [Full Text] [Related]
16. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine. Groppetti A, Parenti M, Dellavedova L, Tirone F. J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120 [Abstract] [Full Text] [Related]
17. Accumulation of hypothalamic endorphins after repeated injections of anorectics which release serotonin. Harsing LG, Yang HY, Costa E. J Pharmacol Exp Ther; 1982 Dec; 223(3):689-94. PubMed ID: 6292396 [Abstract] [Full Text] [Related]
18. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats. Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F. Eur J Pharmacol; 1980 Jan 25; 61(2):203-6. PubMed ID: 7353591 [Abstract] [Full Text] [Related]
19. Effects of serotonin antagonists on the performance of a simple food acquisition task in rats treated with fenfluramine isomers. Thurlby PL, Garattini S, Samanin R. Pharmacol Res Commun; 1985 Dec 25; 17(12):1129-39. PubMed ID: 4095123 [Abstract] [Full Text] [Related]
20. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. Johnson GJ, Leis LA, Dunlop PC, Weir EK. J Thromb Haemost; 2003 Dec 25; 1(12):2663-8. PubMed ID: 14675103 [Abstract] [Full Text] [Related] Page: [Next] [New Search]